# Patheon Pharmaceuticals Inc. – FDA Inspection, Apr 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/3de4da01-f6e4-44da-9ab7-6f8f8d719fe2
Source feed: FDA_Inspections

> FDA inspection 1204466 of Patheon Pharmaceuticals Inc., April 21, 2023. Classification: No Action Indicated (NAI). 16 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204466
- Company Name: Patheon Pharmaceuticals Inc.
- Inspection Date: 2023-04-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1281564 - 2025-09-26](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/ee9dd4e9-579e-445b-8896-014b387bbc11)
- FDA Inspection 1211249 - 2023-07-24
- FDA Inspection 1117783 - 2020-01-14
- [FDA Inspection 1079809 - 2019-02-15](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/b7f1e1d6-1287-4cf0-8ca2-0c82a8009bbb)
- [FDA Inspection 1040994 - 2018-02-14](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/8d2c708c-359e-4f1c-a3f7-515d29d5ca1e)

## Related Officers

- [Investigator](https://www.keypedia.com/people/logan-t-williams/a1febf59-970a-4e4e-9c0c-f4ad385582d7)
- [Issuing Officer](https://www.keypedia.com/people/wenning-chan/973bf578-405d-46cf-b09e-254d6db07c08)

Company: https://www.keypedia.com/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
